Coherus BioSciences, Inc. (CHRS)

Coherus BioSciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	189	371	616	1,225	1,252	1,263
Market Cap Growth	-50.53%	-39.80%	-49.73%	-2.13%	-0.83%	105.10%
Enterprise Value	408	732	900	1,224	1,125	1,274
PE Ratio	-	-1.56	-2.11	-4.27	9.47	14.06
PS Ratio	0.62	1.44	2.92	3.75	2.63	3.55
PB Ratio	-3.29	-1.92	-4.48	12.54	4.46	12.00
P/FCF Ratio	-1.77	-2.13	-2.53	-31.65	8.51	47.59
P/OCF Ratio	-1.76	-2.12	-2.55	-32.74	8.12	44.53
EV/Sales Ratio	1.35	2.84	4.27	3.75	2.36	3.58
EV/EBITDA Ratio	-44.87	-3.82	-3.56	-4.73	7.04	11.03
EV/EBIT Ratio	-27.59	-3.70	-3.47	-4.63	7.17	11.54
EV/FCF Ratio	-3.21	-4.20	-3.70	-31.61	7.65	48.00
Debt / Equity Ratio	-5.86	-2.47	-3.46	4.25	1.47	1.79
Debt / EBITDA Ratio	-43.99	-2.50	-1.88	-1.61	2.59	1.63
Debt / FCF Ratio	-3.15	-2.75	-1.96	-10.73	2.81	7.11
Quick Ratio	1.01	1.14	2.17	3.27	4.79	2.78
Current Ratio	1.17	1.43	2.75	3.64	5.27	2.98
Asset Turnover	0.49	0.49	0.39	0.46	0.66	1.23
Interest Coverage	-0.42	-4.88	-7.98	-11.50	7.41	6.27
Return on Equity (ROE)	40.60%	136.30%	477.10%	-224.10%	58.30%	302.60%
Return on Assets (ROA)	-9.70%	-45.60%	-53.80%	-40.20%	18.40%	30.90%
Return on Capital (ROIC)	-44.77%	-71.23%	-75.85%	-51.41%	21.92%	35.51%
Earnings Yield	-31.51%	-64.15%	-47.36%	-23.43%	10.56%	7.11%
FCF Yield	-80.99%	-47.01%	-39.47%	-3.16%	11.75%	2.10%
Buyback Yield / Dilution	-58.36%	-21.30%	-2.89%	-5.65%	2.42%	-12.53%
Total Shareholder Return	-58.36%	-21.30%	-2.89%	-5.65%	2.42%	-12.53%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).